12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Flutiform fluticasone/formoterol regulatory update

SkyePharma said partner Kyorin submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for flutiform fluticasone/formoterol to treat bronchial asthma in patients who require combination therapy with inhaled...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >